| First Author | Trent CM | Year | 2014 |
| Journal | J Lipid Res | Volume | 55 |
| Issue | 4 | Pages | 645-58 |
| PubMed ID | 24493834 | Mgi Jnum | J:208767 |
| Mgi Id | MGI:5565014 | Doi | 10.1194/jlr.M043471 |
| Citation | Trent CM, et al. (2014) Lipoprotein lipase activity is required for cardiac lipid droplet production. J Lipid Res 55(4):645-58 |
| abstractText | The rodent heart accumulates TGs and lipid droplets during fasting. The sources of heart lipids could be either FFAs liberated from adipose tissue or FAs from lipoprotein-associated TGs via the action of lipoprotein lipase (LpL). Because circulating levels of FFAs increase during fasting, it has been assumed that albumin transported FFAs are the source of lipids within heart lipid droplets. We studied mice with three genetic mutations: peroxisomal proliferator-activated receptor alpha deficiency, cluster of differentiation 36 (CD36) deficiency, and heart-specific LpL deletion. All three genetically altered groups of mice had defective accumulation of lipid droplet TGs. Moreover, hearts from mice treated with poloxamer 407, an inhibitor of lipoprotein TG lipolysis, also failed to accumulate TGs, despite increased uptake of FFAs. TG storage did not impair maximal cardiac function as measured by stress echocardiography. Thus, LpL hydrolysis of circulating lipoproteins is required for the accumulation of lipids in the heart of fasting mice. |
